Charles Schwab Investment Management Inc Madrigal Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 150,746 shares of MDGL stock, worth $50.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150,746
Previous 147,970
1.88%
Holding current value
$50.2 Million
Previous $31.4 Million
48.13%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding MDGL
# of Institutions
308Shares Held
22.4MCall Options Held
743KPut Options Held
666K-
Janus Henderson Group PLC London, X02.48MShares$825 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$679 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$675 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$663 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$657 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...